Alvorlig (neutrofiltal < 0, 5 x 109/ l) under behandlingsperiode 1 blev observeret hos 55% af patienterne og med en varighed ≥ 7 dage hos 20% og totalt set hos 77% af patienterne (39% af behandlingerne).
Severe (neutrophil count < 0.5 x 109/ l) during course 1 was seen in 55% of the patients and with duration ≥ 7 days in 20% and overall in 77% of patients (39% of courses).